| Literature DB >> 12952441 |
Masayuki Inoue1, Takaaki Sato, Masahiro Hirama.
Abstract
Merrilactone A (1) has been shown to possess neurotrophic activity and thus is expected to hold therapeutic potential in the treatment of neurodegeneration diseases. In this paper, we report the total synthesis of (+/-)-1, employing, as key steps, a novel desymmetrization protocol of meso-diketone to construct the core cis-bicyclo[3.3.0]octyl system of 1 (3 --> 2) and a radical cyclization to install the highly congested C9-quaternary carbon (16 --> 17).Entities:
Mesh:
Substances:
Year: 2003 PMID: 12952441 DOI: 10.1021/ja036587+
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419